Stockscreener 앱 받기
23.86
1.28%
-0.31
Alumis Inc 주식(ALMS)의 최신 뉴스
Staar Surgical, Alumis, and more stocks see action from activist investors - MSN
HC Wainwright & Co. hikes Alumis Inc. (ALMS)’s price target to $40 from $20, reiterates buy rating - MSN
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating - Insider Monkey
Alumis (ALMS) Is Up 35.8% After Psoriasis Data And $300M Raise Has The Bull Case Changed? - simplywall.st
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - AOL.com
Alumis (ALMS) price target increased by 79.14% to 36.28 - MSN
Alumis (ALMS) stock jumps as insider filings show $17 buys — what investors are watching next - TechStock²
Why Alumis Inc. Stock Is Surging Right Now - TipRanks
Alumis (NASDAQ:ALMS) Stock Price Up 6.6% Following Insider Buying Activity - MarketBeat
Alumis' Meteoric Rise To $20 From $5 In Just 60 Days On Plaque Psoriasis Trial Results - Nasdaq
Alumis (ALMS) Price Target Increased by 79.14% to 36.28 - Nasdaq
Assessing Alumis (ALMS) Valuation After Positive Phase 3 Psoriasis Data And Follow On Equity Offering - simplywall.st
Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc. - TipRanks
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 588,235 Shares of Stock - MarketBeat
Aug Sectors: Will Alumis Inc stock benefit from automation2025 Performance Recap & Low Drawdown Momentum Trade Ideas - moha.gov.vn
Akkaraju of Alumis buys shares worth $9.9 million By Investing.com - Investing.com Nigeria
Akkaraju of Alumis buys shares worth $9.9 million - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Warren Buffett, Balyasny Asset Management, Schonfeld Strategic Advisors, Renaissance Technologies, Anson Investments, Limoneira Co (LMNR), Alumis Inc (ALMS), and More - Insider Monkey
Alumis (NASDAQ:ALMS) Reaches New 1-Year High on Insider Buying Activity - MarketBeat
Alumis Inc stock hits all-time high at 22.33 USD - Investing.com India
Why Alumis Inc. Stock Is Quietly Surging Higher - TipRanks
Support Test: Is Alumis Inc stock a buy on dipsMarket Activity Summary & Weekly Top Gainers Alerts - Bộ Nội Vụ
Alumis Inc. Stock (ALMS) Opinions on Phase 3 Trial Results - Quiver Quantitative
Latham & Watkins Advises on Alumis’ Upsized US$345 Million Public Offering of Common Stock - Legal Desire Media and Insights
Insider Buying: Alumis (NASDAQ:ALMS) Major Shareholder Buys 411,764 Shares of Stock - MarketBeat
Alumis Insider Bought Shares Worth $6,999,988, According to a Recent SEC Filing - marketscreener.com
Alumis (NASDAQ:ALMS) Major Shareholder Buys $6,999,988.00 in Stock - MarketBeat
Foresite Labs buys Alumis (ALMS) shares worth $7 million - Investing.com
Foresite Labs buys Alumis (ALMS) shares worth $7 million By Investing.com - Investing.com Canada
Alumis (ALMS) director Tananbaum buys shares worth $6.99m By Investing.com - Investing.com South Africa
Foresite Capital buys Alumis (ALMS) shares worth $7m By Investing.com - Investing.com South Africa
Foresite Capital buys Alumis (ALMS) shares worth $7m - Investing.com
Aug Decliners: Is Alumis Inc gaining market share2025 Price Momentum & Low Drawdown Trading Strategies - baoquankhu1.vn
Investment Review: Is Alumis Inc gaining market shareShort Setup & Verified Momentum Stock Watchlist - baoquankhu1.vn
Alumis Stock Skyrockets Amid Significant Drug Trial Success - StocksToTrade
Alumis Stock Soars After Phase 3 Trial Success - timothysykes.com
Alumis stock hits record high as Wall Street cheers phase 3 psoriasis 'win' — analysts see best-in-class potential - MSN
Alumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Alumis announces phase 3 trial of envudeucitinib met all primary endpoints - MSN
Alumis raises $345.1 million in upsized public offering By Investing.com - Investing.com India
Alumis raises $345.1 million in upsized public offering - Investing.com
Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Alumis Inc. Announces Closing of $345.1 Million Upsized Public Offering of Common Stock - Quiver Quantitative
ALMSAlumis Inc Latest Stock News & Market Updates - Stock Titan
Can Alumis Inc. stock hit record highs againPerformance Line Overview & updated model highlights and notes - ulpravda.ru
Alumis launches sizable common stock public offering - TipRanks
Can Alumis Inc. stock maintain growth trajectoryJuly 2025 Movers & Verified Momentum Stock Watchlist - ulpravda.ru
What's Going On With Alumis Stock Thursday? - Sahm
Alumis (ALMS) Is Up 83.6% After Phase 3 Psoriasis Win And NDA PlanHas The Bull Case Changed? - Sahm
4.73%
0.92%
자본화:
|
볼륨(24시간):